These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11996195)

  • 21. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Pittrow D; Bohlscheid V
    Fortschr Med Orig; 2003; 121(1):27-32. PubMed ID: 15117066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy as first-line treatment of arterial hypertension.
    Ruzicka M; Leenen FH
    Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
    Malacco E; Piazza S; Carretta R; Di Somma S; Mugellini A; Bertocchi F; Palatini P;
    Int J Clin Pharmacol Ther; 2002 Jun; 40(6):263-9. PubMed ID: 12078940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
    Coca A
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):147-59. PubMed ID: 17338661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose combinations versus monotherapies in the treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 1997 Mar; 15(2):S17-20. PubMed ID: 9218193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension: the rediscovery of combination therapy.
    Prisant LM; Doll NC
    Geriatrics; 1997 Nov; 52(11):28-30, 33-8. PubMed ID: 9371101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifactorial nature of hypertension: the greatest challenge for its treatment?
    Waeber B; Brunner HR; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
    Messerli FH; Michalewicz L
    J Hypertens Suppl; 1998 Jan; 16(1):S81-4. PubMed ID: 9534103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How to evaluate the contribution of fixed dose combinations: the standpoint of the methodologist].
    Chatellier G
    J Hum Hypertens; 1995 Aug; 9 Suppl 4():S27-33. PubMed ID: 7674270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic principles and possible variations in combination antihypertensive therapy].
    Scholze J
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):155-63. PubMed ID: 9244658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A First-Line Treatment Option for Elderly Hypertensive Patients: A Low-Dose Multimechanism à -Blocker/Diuretic.
    Burris JF; Mroczek WJ
    Am J Geriatr Cardiol; 1997 Jan; 6(1):40-46. PubMed ID: 11416408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.
    Bakris GL
    J Clin Hypertens (Greenwich); 1999 Oct; 1(2):141-147. PubMed ID: 11416606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.